{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:10:52Z","timestamp":1790950252471,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T00:00:00Z","timestamp":1687737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-023-02086-7","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T07:02:56Z","timestamp":1687762976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The evolving landscape of involvement of DTYMK enzymes in cancer"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-8560","authenticated-orcid":false,"given":"Nadia","family":"Heydari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3596-501X","authenticated-orcid":false,"given":"Mahsa","family":"Mahdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-7505","authenticated-orcid":false,"given":"Seyyed Mehdi","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,26]]},"reference":[{"issue":"6264","key":"2086_CR1","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.aac7041","volume":"350","author":"T Wang","year":"2015","unstructured":"Wang T, Hughes NW, Krupczak KM, Post Y, Wei JJ, Lander ES, Sabatini DM. Identification and characterization of essential genes in the human genome. Science (NY). 2015;350(6264):1096\u2013101.","journal-title":"Science (NY)"},{"key":"2086_CR2","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/nar\/gkw1013","volume":"45","author":"WH Chen","year":"2017","unstructured":"Chen WH, Chen X, Zhao XM, Bork P. OGEE v2: an update of the online gene essentiality database with special focus on differentially essential genes in human cancer cell lines. Nucleic Acids Res. 2017;45:940\u20134.","journal-title":"Nucleic Acids Res"},{"key":"2086_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cca.2019.06.028","volume":"496","author":"W-LYC Lama","year":"2019","unstructured":"Lama W-LYC, Linga T, Wonga K, Lawa C. Deoxythymidylate kinase, DTYMK, is a novel gene for mitochondrial DNA depletion syndrome. Clin Chim Acta. 2019;496:93\u20139.","journal-title":"Clin Chim Acta"},{"issue":"12","key":"2086_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41419-021-04375-3","volume":"12","author":"F Sun","year":"2021","unstructured":"Sun F, et al. Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin. Cell Death Dis. 2021;12(12):1093.","journal-title":"Cell Death Dis"},{"key":"2086_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00401-021-02394-0","volume":"143","author":"JMB Vanoevelen","year":"2022","unstructured":"Vanoevelen JMB, Grashorn J, Lambrichs E, Kamsteeg E-J, Bok L, Wevers R, Van der Knaap M, Bugiani M, Frisk JMH, et al. DTYMK is essential for genome integrity and neuronal survival. Acta Neuropathol. 2022;143:245\u201362.","journal-title":"Acta Neuropathol"},{"key":"2086_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/2159-8290.CD-13-0015","volume":"3","author":"YM Liu","year":"2013","unstructured":"Liu YM, Cowley G, Carretero J, Liu Q, Nieland T, Xu C, Cohoon T, Gao P, Zhang Y, et al. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discov. 2013;3:870\u20139.","journal-title":"Cancer Discov"},{"issue":"8","key":"2086_CR7","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1158\/0008-5472.CAN-07-3069","volume":"68","author":"C-M Hu","year":"2008","unstructured":"Hu C-M, Chang Z-F. Synthetic lethality by lentiviral short hairpin RNA silencing of thymidylate kinase and doxorubicin in colon cancer cells regardless of the p53 status. Can Res. 2008;68(8):2831\u201340.","journal-title":"Can Res"},{"issue":"Pt 4","key":"2086_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1107\/s2059798318002267","volume":"74","author":"SK Chaudhary","year":"2018","unstructured":"Chaudhary SK, Jeyakanthan J, Sekar K. Structural and functional roles of dynamically correlated residues in thymidylate kinase. Acta Crystallogr D. 2018;74(Pt 4):341\u201354. https:\/\/doi.org\/10.1107\/s2059798318002267.","journal-title":"Acta Crystallogr D"},{"issue":"4","key":"2086_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/nar\/19.4.823","volume":"19","author":"J-Y Su","year":"1991","unstructured":"Su J-Y, Sclafani RA. Molecular cloning and expression of the human deoxythymidylate kinase gene in yeast. Nucleic Acids Res. 1991;19(4):823\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2086_CR10","first-page":"1333","volume":"6","author":"P Liang","year":"1995","unstructured":"Liang P, et al. Molecular characterization of the murine thymidylate kinase gene. Cell Growth Differ. 1995;6(10):1333\u20138.","journal-title":"Cell Growth Differ"},{"issue":"16","key":"2086_CR11","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1101\/gad.1322905","volume":"19","author":"Y-YKP-Y Ke","year":"2005","unstructured":"Ke Y-YKP-Y, Hu C-M, Chang Z-F. Control of dTTP pool size by anaphase promoting complex\/cyclosome is essential for the maintenance of genetic stability. Genes Dev. 2005;19(16):1920\u201333.","journal-title":"Genes Dev"},{"issue":"32","key":"2086_CR12","doi-asserted-by":"publisher","first-page":"33035","DOI":"10.1074\/jbc.R400007200","volume":"279","author":"DR Evans","year":"2004","unstructured":"Evans DR, Guy HI. Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J Biol Chem. 2004;279(32):33035\u20138.","journal-title":"J Biol Chem"},{"issue":"9","key":"2086_CR13","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.molmed.2005.07.003","volume":"11","author":"M L\u00f6ffler","year":"2005","unstructured":"L\u00f6ffler M, et al. Pyrimidine pathways in health and disease. Trends Mol Med. 2005;11(9):430\u20137.","journal-title":"Trends Mol Med"},{"issue":"32","key":"2086_CR14","doi-asserted-by":"publisher","first-page":"33035","DOI":"10.1074\/jbc.R400007200","volume":"279","author":"DR Evans","year":"2004","unstructured":"Evans DR. Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J Biol Chem. 2004;279(32):33035\u20138.","journal-title":"J Biol Chem"},{"issue":"12","key":"2086_CR15","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1073\/pnas.86.12.4382","volume":"86","author":"JP Simmer","year":"1989","unstructured":"Simmer JP, et al. Mammalian aspartate transcarbamylase (ATCase): sequence of the ATCase domain and interdomain linker in the CAD multifunctional polypeptide and properties of the isolated domain. Proc Natl Acad Sci USA. 1989;86(12):4382\u20136. https:\/\/doi.org\/10.1073\/pnas.86.12.4382.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"2086_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nchembio.2050","volume":"12","author":"RM Deans","year":"2016","unstructured":"Deans RM, et al. Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification. Nat Chem Biol. 2016;12(5):361\u20136. https:\/\/doi.org\/10.1038\/nchembio.2050.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2086_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.str.2007.10.020","volume":"16","author":"JG Wittmann","year":"2008","unstructured":"Wittmann JG, et al. Structures of the human orotidine-5\u2019-monophosphate decarboxylase support a covalent mechanism and provide a framework for drug design. Structure. 2008;16(1):82\u201392. https:\/\/doi.org\/10.1016\/j.str.2007.10.020.","journal-title":"Structure"},{"issue":"6","key":"2086_CR18","first-page":"1624","volume":"62","author":"JY Liou","year":"2002","unstructured":"Liou JY, et al. Characterization of human UMP\/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. Cancer Res. 2002;62(6):1624\u201331.","journal-title":"Cancer Res"},{"issue":"26","key":"2086_CR19","doi-asserted-by":"publisher","first-page":"10413","DOI":"10.1074\/jbc.H118.003717","volume":"293","author":"BL Greene","year":"2018","unstructured":"Greene BL, Nocera DG, Stubbe J. Basis of dATP inhibition of RNRs. J Biol Chem. 2018;293(26):10413\u20134. https:\/\/doi.org\/10.1074\/jbc.H118.003717.","journal-title":"J Biol Chem"},{"issue":"32","key":"2086_CR20","doi-asserted-by":"publisher","first-page":"13449","DOI":"10.1074\/jbc.M117.787267","volume":"292","author":"D Chen","year":"2017","unstructured":"Chen D, et al. Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states. J Biol Chem. 2017;292(32):13449\u201358. https:\/\/doi.org\/10.1074\/jbc.M117.787267.","journal-title":"J Biol Chem"},{"issue":"22","key":"2086_CR21","doi-asserted-by":"publisher","first-page":"21169","DOI":"10.1074\/jbc.M412343200","volume":"280","author":"DLJ Cao","year":"2005","unstructured":"Cao DLJ, Kim B, Pizzorno G. Abnormalities in uridine homeostatic regulation and pyrimidine nucleotide metabolism as a consequence of the deletion of the uridine phosphorylase gene. J Biol Chem. 2005;280(22):21169\u201375.","journal-title":"J Biol Chem"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0969-2126(00)00149-0","volume":"8","author":"NS Ostermann","year":"2000","unstructured":"Ostermann NS, Brundiers R, Konrad M, Reinstein J, Veit T, Goody RS, Lavie A. Insights into the phosphoryltransfer mechanism of human thymidylate kinase gained from crystal structures of enzyme complexes along the reaction coordinate. Structure. 2000;8:629\u201342.","journal-title":"Structure"},{"issue":"3","key":"2086_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/15257770.2021.2023748","volume":"41","author":"J Hu Frisk","year":"2022","unstructured":"Hu Frisk J, et al. Structural and functional analysis of human thymidylate kinase isoforms. Nucleosides Nucleotides Nucleic Acids. 2022;41(3):321\u201332. https:\/\/doi.org\/10.1080\/15257770.2021.2023748.","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"44","key":"2086_CR24","doi-asserted-by":"publisher","first-page":"77734","DOI":"10.18632\/oncotarget.20774","volume":"8","author":"H-W Yeh","year":"2017","unstructured":"Yeh H-W, et al. Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis. Oncotarget. 2017;8(44):77734.","journal-title":"Oncotarget"},{"key":"2086_CR25","doi-asserted-by":"crossref","unstructured":"Guo Y et al (2021) DTYMK expression predicts prognosis and chemotherapeutic response and correlates with immune infiltration in hepatocellular carcinoma. J Hepatocell Carcinoma 871\u2013885.","DOI":"10.2147\/JHC.S312604"},{"issue":"17","key":"2086_CR26","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1080\/15384101.2021.1958502","volume":"20","author":"T Zhou","year":"2021","unstructured":"Zhou T, et al. DTYMK promote hepatocellular carcinoma proliferation by regulating cell cycle. Cell Cycle. 2021;20(17):1681\u201391.","journal-title":"Cell Cycle"},{"key":"2086_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2018.02.032","volume":"655","author":"N Heydari","year":"2018","unstructured":"Heydari N, et al. Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer. Gene. 2018;655:25\u20139.","journal-title":"Gene"},{"issue":"4","key":"2086_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3320","volume":"23","author":"Z Nashtahosseini","year":"2021","unstructured":"Nashtahosseini Z, et al. Circulating status of microRNAs 660\u20135p and 210\u20133p in breast cancer patients. J Gene Med. 2021;23(4): e3320.","journal-title":"J Gene Med"},{"key":"2086_CR29","doi-asserted-by":"publisher","first-page":"5448","DOI":"10.3389\/fonc.2021.625566","volume":"11","author":"G He","year":"2021","unstructured":"He G, et al. Mir-148b-3p regulates the expression of DTYMK to drive hepatocellular carcinoma cell proliferation and metastasis. Front Oncol. 2021;11:5448.","journal-title":"Front Oncol"},{"issue":"19","key":"2086_CR30","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.18632\/aging.204308","volume":"14","author":"X Chen","year":"2022","unstructured":"Chen X, et al. Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma. Aging (Albany NY). 2022;14(19):7866.","journal-title":"Aging (Albany NY)"},{"key":"2086_CR31","unstructured":"Wang W, et al (2016) Elevated expression of DTYMK is associated with poor prognosis in patients with non-small cell lung cancer. Int J Clin Exp Med 9(11)."},{"key":"2086_CR32","doi-asserted-by":"crossref","unstructured":"Zhang Y et al (2022) Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma. Biosci Rep 42(10):BSR20221170.","DOI":"10.1042\/BSR20221170"},{"key":"2086_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.887059","author":"T Lan","year":"2022","unstructured":"Lan T, et al. Deoxythymidylate kinase as a promising marker for predicting prognosis and immune cell infiltration of pan-cancer. Front Mol Biosci. 2022. https:\/\/doi.org\/10.3389\/fmolb.2022.887059.","journal-title":"Front Mol Biosci"},{"key":"2086_CR34","doi-asserted-by":"publisher","unstructured":"Zhou L et al (2022) Relationship between up-regulation of DTYMK expression and immune infiltration for the prognosis of lung adenocarcinoma. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-1693054\/v1.","DOI":"10.21203\/rs.3.rs-1693054\/v1"},{"key":"2086_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s11302-020-09711-4","volume":"16","author":"H Wang","year":"2020","unstructured":"Wang H, et al. High expression levels of pyrimidine metabolic rate\u2013limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on the cancer genome atlas and gene expression omnibus datasets. Purinergic Signal. 2020;16:347\u201366.","journal-title":"Purinergic Signal"},{"issue":"8","key":"2086_CR36","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1158\/2159-8290.CD-13-0015","volume":"3","author":"Y Liu","year":"2013","unstructured":"Liu Y, et al. Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung canceridentifying Lkb1-mutant synthetic lethal targets. Cancer Discov. 2013;3(8):870\u20139.","journal-title":"Cancer Discov"},{"issue":"3","key":"2086_CR37","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1677\/jme.0.0320719","volume":"32","author":"L Cicatiello","year":"2004","unstructured":"Cicatiello L, et al. A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. J Mol Endocrinol. 2004;32(3):719\u201375.","journal-title":"J Mol Endocrinol"},{"key":"2086_CR38","doi-asserted-by":"crossref","unstructured":"Chow L, et al (2012) 23P expression of beta-iii tubulin, Foxo 3 protein and deoxythymidine kinase in breast cancer patients receiving neoadjuvant chemotherapy. Ann Oncol 23:ii21.","DOI":"10.1016\/S0923-7534(19)65668-1"},{"issue":"1","key":"2086_CR39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/cbf.3672","volume":"40","author":"SM Mir","year":"2022","unstructured":"Mir SM, et al. Melatonin: a smart molecule in the DNA repair system. Cell Biochem Funct. 2022;40(1):4\u201316.","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"2086_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ccr.2012.04.038","volume":"22","author":"C-M Hu","year":"2012","unstructured":"Hu C-M, et al. Tumor cells require thymidylate kinase to prevent dUTP incorporation during DNA repair. Cancer Cell. 2012;22(1):36\u201350.","journal-title":"Cancer Cell"},{"issue":"2","key":"2086_CR41","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1096\/fj.201800856R","volume":"33","author":"C-M Hu","year":"2019","unstructured":"Hu C-M, et al. Thymidylate kinase is critical for DNA repair via ATM-dependent Tip60 complex formation. FASEB J. 2019;33(2):2017\u201325.","journal-title":"FASEB J"},{"issue":"5","key":"2086_CR42","first-page":"1279","volume":"24","author":"PM De Angelis","year":"2004","unstructured":"De Angelis PM, et al. Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil. Int J Oncol. 2004;24(5):1279\u201388.","journal-title":"Int J Oncol"},{"issue":"5","key":"2086_CR43","doi-asserted-by":"publisher","first-page":"37","DOI":"10.52547\/mlj.16.5.37","volume":"16","author":"P Zeinali","year":"2022","unstructured":"Zeinali P, et al. High dose of 3, 7-dimethyl-1-propargylxanthine induces cell death in YM-1 and KYSE30 cancer cell lines. Med Lab J. 2022;16(5):37\u201342.","journal-title":"Med Lab J"},{"key":"2086_CR44","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s13277-014-2744-9","volume":"36","author":"M Hamzeloo-Moghadam","year":"2015","unstructured":"Hamzeloo-Moghadam M, et al. Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells. Tumor Biol. 2015;36:1191\u20138.","journal-title":"Tumor Biol"},{"issue":"Supplement 2","key":"2086_CR45","first-page":"1764","volume":"50","author":"Y Yuka","year":"2009","unstructured":"Yuka Y, et al. Correlation of ENT1, TK1, dNT, TMPK, and PCNA with 18F-FLT uptake in gastric cancer. J Nucl Med. 2009;50(Supplement 2):1764.","journal-title":"J Nucl Med"},{"key":"2086_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.989460","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors. Front Genet. 2022. https:\/\/doi.org\/10.3389\/fgene.2022.989460.","journal-title":"Front Genet"},{"key":"2086_CR47","doi-asserted-by":"publisher","unstructured":"Zhou L et al (2022) Relationship between up-regulation of DTYMK expression and immune infiltration for the prognosis of lung adenocarcinoma. https:\/\/doi.org\/10.21203\/rs.3.rs-1693054\/v1","DOI":"10.21203\/rs.3.rs-1693054\/v1"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-023-02086-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-023-02086-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T03:37:51Z","timestamp":1690342671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-023-02086-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,26]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1007\/s12032-023-02086-7","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,26]]},"assertion":[{"value":"6 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"213"}}